View in EDS HTML Full Text PDF Full Text

41 | PROSPECTIVE VALIDATION OF END OF TREATMENT ctDNA‐MRD BY PhasED‐Seq IN DLBCL PATIENTS FROM A NATIONAL HOVON TRIAL.

Saved in:
Bibliographic Details
Title: 41 | PROSPECTIVE VALIDATION OF END OF TREATMENT ctDNA‐MRD BY PhasED‐Seq IN DLBCL PATIENTS FROM A NATIONAL HOVON TRIAL.
Authors: Chamuleau, M. E., Wang, S., Nijland, M., Strobbe, L., Oosterveld, M., Boersma, R., Koene, H., Klerk, C. P., de Jongh, E., Koster, A., Pruijt, H., van der Poel, M., van Werkhoven, E., Dinmohamed, A., van den Bosch, T., Sworder, B. J., Close, S., Brown, K., Meek, S., Alizadeh, A. A., et al
Source: Hematological oncology 2025 Supplement; Vol. 43.
Journal Info: Publisher: Wiley-Blackwell ISSN: 0278-0232
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: EPTOC187726377
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 41 | PROSPECTIVE VALIDATION OF END OF TREATMENT ctDNA‐MRD BY PhasED‐Seq IN DLBCL PATIENTS FROM A NATIONAL HOVON TRIAL.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chamuleau%2C+M%2E+E%2E%22">Chamuleau, M. E.</searchLink><br /><searchLink fieldCode="AU" term="%22Wang%2C+S%2E%22">Wang, S.</searchLink><br /><searchLink fieldCode="AU" term="%22Nijland%2C+M%2E%22">Nijland, M.</searchLink><br /><searchLink fieldCode="AU" term="%22Strobbe%2C+L%2E%22">Strobbe, L.</searchLink><br /><searchLink fieldCode="AU" term="%22Oosterveld%2C+M%2E%22">Oosterveld, M.</searchLink><br /><searchLink fieldCode="AU" term="%22Boersma%2C+R%2E%22">Boersma, R.</searchLink><br /><searchLink fieldCode="AU" term="%22Koene%2C+H%2E%22">Koene, H.</searchLink><br /><searchLink fieldCode="AU" term="%22Klerk%2C+C%2E+P%2E%22">Klerk, C. P.</searchLink><br /><searchLink fieldCode="AU" term="%22de+Jongh%2C+E%2E%22">de Jongh, E.</searchLink><br /><searchLink fieldCode="AU" term="%22Koster%2C+A%2E%22">Koster, A.</searchLink><br /><searchLink fieldCode="AU" term="%22Pruijt%2C+H%2E%22">Pruijt, H.</searchLink><br /><searchLink fieldCode="AU" term="%22van+der+Poel%2C+M%2E%22">van der Poel, M.</searchLink><br /><searchLink fieldCode="AU" term="%22van+Werkhoven%2C+E%2E%22">van Werkhoven, E.</searchLink><br /><searchLink fieldCode="AU" term="%22Dinmohamed%2C+A%2E%22">Dinmohamed, A.</searchLink><br /><searchLink fieldCode="AU" term="%22van+den+Bosch%2C+T%2E%22">van den Bosch, T.</searchLink><br /><searchLink fieldCode="AU" term="%22Sworder%2C+B%2E+J%2E%22">Sworder, B. J.</searchLink><br /><searchLink fieldCode="AU" term="%22Close%2C+S%2E%22">Close, S.</searchLink><br /><searchLink fieldCode="AU" term="%22Brown%2C+K%2E%22">Brown, K.</searchLink><br /><searchLink fieldCode="AU" term="%22Meek%2C+S%2E%22">Meek, S.</searchLink><br /><searchLink fieldCode="AU" term="%22Alizadeh%2C+A%2E+A%2E%22">Alizadeh, A. A.</searchLink><br />et al
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228307268%22">Hematological oncology</searchLink> 2025 Supplement; Vol. 43.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>ISSN: </i>0278-0232
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=EPTOC187726377
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hon.70093_41
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1
    Titles:
      – TitleFull: 41 | PROSPECTIVE VALIDATION OF END OF TREATMENT ctDNA‐MRD BY PhasED‐Seq IN DLBCL PATIENTS FROM A NATIONAL HOVON TRIAL.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chamuleau, M. E.
      – PersonEntity:
          Name:
            NameFull: Wang, S.
      – PersonEntity:
          Name:
            NameFull: Nijland, M.
      – PersonEntity:
          Name:
            NameFull: Strobbe, L.
      – PersonEntity:
          Name:
            NameFull: Oosterveld, M.
      – PersonEntity:
          Name:
            NameFull: Boersma, R.
      – PersonEntity:
          Name:
            NameFull: Koene, H.
      – PersonEntity:
          Name:
            NameFull: Klerk, C. P.
      – PersonEntity:
          Name:
            NameFull: de Jongh, E.
      – PersonEntity:
          Name:
            NameFull: Koster, A.
      – PersonEntity:
          Name:
            NameFull: Pruijt, H.
      – PersonEntity:
          Name:
            NameFull: van der Poel, M.
      – PersonEntity:
          Name:
            NameFull: van Werkhoven, E.
      – PersonEntity:
          Name:
            NameFull: Dinmohamed, A.
      – PersonEntity:
          Name:
            NameFull: van den Bosch, T.
      – PersonEntity:
          Name:
            NameFull: Sworder, B. J.
      – PersonEntity:
          Name:
            NameFull: Close, S.
      – PersonEntity:
          Name:
            NameFull: Brown, K.
      – PersonEntity:
          Name:
            NameFull: Meek, S.
      – PersonEntity:
          Name:
            NameFull: Alizadeh, A. A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 06
              Text: 2025 Supplement
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1099-1069
          Numbering:
            – Type: volume
              Value: 43
          Titles:
            – TitleFull: Hematological oncology
              Type: main
ResultId 1